Literature DB >> 24008334

A functional analysis of the influence of β3-adrenoceptors on the rat micturition cycle.

Prajni Sadananda1, Marcus J Drake, Julian F R Paton, Anthony E Pickering.   

Abstract

Dysfunctions of the lower urinary tract, such as overactive bladder syndrome and incontinence, are the product of storage failure. Spontaneous regional bladder wall movements [nonmicturition contractions (NMCs)] are proposed to generate afferent activity that signals volume status to the central nervous system. The sympathetic nervous system, via activation of β-adrenoceptors (β-ARs), causes bladder relaxation and promotes urine storage. We hypothesized that β-AR regulation of micturition is mediated by suppression of NMCs. We used an unanesthetized, decerebrate, artificially perfused rat preparation that allows simultaneous cystometry with external urethral sphincter and pelvic afferent nerve recordings. Systemic isoprenaline (10 nM to 1 µM) increased intervoid interval and bladder compliance accompanied by a decrease in NMC amplitude, voiding pressure, and voiding threshold. Isoprenaline also reduced arterial pressure and increased heart rate. The β3-AR agonist mirabegron (10-100 nM) increased intervoid interval and bladder compliance and reduced NMC amplitude, yet preserved active voiding function and had no effect on arterial pressure or heart rate. All of these effects of mirabegron were blocked by the selective β3-AR antagonist N-[[3-[(2S)-2-hydroxy-3-[[2-[4-[(phenylsulfonyl)amino] phenyl]ethyl]amino]propoxy]phenyl]methyl]-acetamide (L748,337), which alone shortened intervoid interval and decreased bladder compliance-suggesting the presence of a basal β3-AR-mediated sympathetic tone. Similar effects of mirabegron were seen in an acetic acid-sensitized bladder preparation and in preparations after loss of spinobulbar reflex bladder control. The β3-AR-mediated increase in intervoid interval correlated with increased bladder compliance but not with the decrease in NMC amplitude. These findings indicate that β3-adrenoceptors have a selective effect that improves urine storage by increasing compliance without affecting the active components of voiding.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24008334      PMCID: PMC3807064          DOI: 10.1124/jpet.113.207340

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

Review 1.  β-adrenoceptor agonist effects in experimental models of bladder dysfunction.

Authors:  Martin C Michel; Peter Ochodnicky; Yukio Homma; Yasuhiko Igawa
Journal:  Pharmacol Ther       Date:  2011-04-12       Impact factor: 12.310

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

3.  A decerebrate, artificially-perfused in situ preparation of rat: utility for the study of autonomic and nociceptive processing.

Authors:  Anthony E Pickering; Julian F R Paton
Journal:  J Neurosci Methods       Date:  2006-02-23       Impact factor: 2.390

4.  Urothelial beta-3 adrenergic receptors in the rat bladder.

Authors:  F Aura Kullmann; Thomas R Downs; Debra E Artim; Brian J Limberg; Mansi Shah; Dan Contract; William C de Groat; Jan S Rosenbaum
Journal:  Neurourol Urodyn       Date:  2011-01       Impact factor: 2.696

5.  Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.

Authors:  Y Igawa; Y Yamazaki; H Takeda; K Hayakawa; M Akahane; Y Ajisawa; T Yoneyama; O Nishizawa; K E Andersson
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.

Authors:  Toshiyuki Takasu; Masashi Ukai; Shuichi Sato; Tetsuo Matsui; Itsuro Nagase; Tatsuya Maruyama; Masao Sasamata; Keiji Miyata; Hisashi Uchida; Osamu Yamaguchi
Journal:  J Pharmacol Exp Ther       Date:  2007-02-09       Impact factor: 4.030

7.  Role of the beta(3)-adrenoceptor in urine storage in the rat: comparison between the selective beta(3)-adrenoceptor agonist, CL316, 243, and various smooth muscle relaxants.

Authors:  H Takeda; Y Yamazaki; M Akahane; Y Igawa; Y Ajisawa; O Nishizawa
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

8.  Involvement of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor muscle relaxation and micturition reflex.

Authors:  Aurore Deba; Stefano Palea; Celine Rouget; Timothy D Westfall; Philippe Lluel
Journal:  Eur J Pharmacol       Date:  2009-07-18       Impact factor: 4.432

9.  Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.

Authors:  Naoki Aizawa; Yukio Homma; Yasuhiko Igawa
Journal:  Eur Urol       Date:  2012-09-05       Impact factor: 20.096

Review 10.  The neural control of micturition.

Authors:  Clare J Fowler; Derek Griffiths; William C de Groat
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

View more
  17 in total

1.  Beta adrenergic modulation of spontaneous microcontractions and electrical field-stimulated contractions in isolated strips of rat urinary bladder from normal animals and animals with partial bladder outflow obstruction.

Authors:  J I Gillespie; C Rouget; S Palea; C Granato; C Korstanje
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-07       Impact factor: 3.000

2.  The expression of β3-adrenoceptor and muscarinic type 3 receptor immuno-reactivity in the major pelvic ganglion of the rat.

Authors:  J Eastham; C Stephenson; K Korstanje; J I Gillespie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-04-29       Impact factor: 3.000

Review 3.  β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Authors:  Yasuhiko Igawa; Naoki Aizawa; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-05-03       Impact factor: 8.739

4.  Prostaglandin E2 excitatory effects on rat urinary bladder: a comparison between the β-adrenoceptor modulation of non-voiding activity in vivo and micro-contractile activity in vitro.

Authors:  C Granato; C Korstanje; V Guilloteau; C Rouget; S Palea; J I Gillespie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-11       Impact factor: 3.000

Review 5.  Clinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome.

Authors:  Monika Vij; Marcus J Drake
Journal:  Ther Adv Urol       Date:  2015-10

6.  Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial.

Authors:  Mike Herdman; Jameel Nazir; Zalmai Hakimi; Emad Siddiqui; Moses Huang; Marco Pavesi; Scott MacDiarmid; Marcus J Drake; Nancy Devlin
Journal:  Patient       Date:  2017-12       Impact factor: 3.883

Review 7.  The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.

Authors:  Karl-Erik Andersson; Nurul Choudhury; Jean-Nicolas Cornu; Moses Huang; Cees Korstanje; Emad Siddiqui; Philip Van Kerrebroeck
Journal:  Ther Adv Urol       Date:  2018-07-06

Review 8.  The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity.

Authors:  Marcus J Drake; Anthony Kanai; Dominika A Bijos; Youko Ikeda; Irina Zabbarova; Bahareh Vahabi; Christopher H Fry
Journal:  BJU Int       Date:  2016-08-23       Impact factor: 5.588

Review 9.  What are the origins and relevance of spontaneous bladder contractions? ICI-RS 2017.

Authors:  Marcus J Drake; Christopher H Fry; Hikaru Hashitani; Ruth Kirschner-Hermanns; Mohammad S Rahnama'i; John E Speich; Hikaru Tomoe; Anthony J Kanai; Karen D McCloskey
Journal:  Neurourol Urodyn       Date:  2018-01-23       Impact factor: 2.696

10.  Urothelial ATP exocytosis: regulation of bladder compliance in the urine storage phase.

Authors:  Hiroshi Nakagomi; Mitsuharu Yoshiyama; Tsutomu Mochizuki; Tatsuya Miyamoto; Ryohei Komatsu; Yoshio Imura; Yosuke Morizawa; Miki Hiasa; Takaaki Miyaji; Satoru Kira; Isao Araki; Kayoko Fujishita; Keisuke Shibata; Eiji Shigetomi; Youichi Shinozaki; Reiko Ichikawa; Hisayuki Uneyama; Ken Iwatsuki; Masatoshi Nomura; William C de Groat; Yoshinori Moriyama; Masayuki Takeda; Schuichi Koizumi
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.